MRAR - Programme Pluriannuel de Recherche sur les Maladies Rares (MRAR)
Correction du phénotype CMT1A par des molécules modulant l'expression du gène PMP22: rôle de l'acide ascorbique et d'autres molécules. – CMTHER
Project coordination
Michel FONTES (Organisme de recherche)
The author of this summary is the project coordinator, who is responsible for the content of this summary. The ANR declines any responsibility as for its contents.
Partner
Help of the ANR 350,000 euros
Beginning and duration of the scientific project:
- 36 Months
